Trademark: 85743526
Word
RENAISSANCE PHARMA
Status
Dead
Status Code
710
Status Date
Friday, June 5, 2020
Serial Number
85743526
Registration Number
4419742
Registration Date
Tuesday, October 15, 2013
Mark Type
3000
Filing Date
Tuesday, October 2, 2012
Published for Opposition
Tuesday, March 26, 2013
Cancellation Date
Friday, June 5, 2020

Trademark Owner History
RENAISSANCE PHARMA INC. - Original Registrant

Classifications
5 Pharmaceutical products and devices, namely, Athletes' foot preparations; Bismuth preparations for pharmaceutical use; Pharmaceutical preparations for use in ocular disorders; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the relief of pain; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for the treatment of allergies; Pharmaceutical preparations for the treatment of bacterial skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of carpal tunnel syndrome; Pharmaceutical preparations for the treatment of chronic pain; Pharmaceutical preparations for the treatment of dental and oral diseases; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; Pharmaceutical preparations for the treatment of drug and alcohol abuse; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of genitor-urinary and pelvic diseases, disorders and infections, namely, infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of headaches; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of metabolic disorders, namely, diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of migraine; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of myalgia and neuralgia; Pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; Pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; Pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; Pharmaceutical preparations for the treatment of psychiatric and other brain diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, seizures; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; Pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of skin irritations, namely, bee stings, sunburn, rashes, sores, corns, calluses, and acne; Pharmaceutical preparations for the treatment of smoking cessation; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system, infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; Pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of varicose veins; Pharmaceutical preparations for the treatment of vascular diseases; Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Pharmaceutical preparations for use in gastroenterology; Thyroid hormonal preparations; Vaginal antifungal preparations
Color is not claimed as a feature of the mark.
"PHARMA"
The mark consists of the words "RENAISSANCE PHARMA" in stylized form with a representation of a butterfly situated to the upper right.

Trademark Events
Jun 5, 2020
Cancelled Sec. 8 (6-Yr)
Oct 15, 2018
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 15, 2013
Registered-Principal Register
Sep 7, 2013
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 6, 2013
Law Office Registration Review Completed
Sep 6, 2013
Allowed Principal Register - Sou Accepted
Jul 30, 2013
Statement Of Use Processing Complete
Jul 4, 2013
Use Amendment Filed
Jul 26, 2013
Case Assigned To Intent To Use Paralegal
Jul 4, 2013
Teas Statement Of Use Received
May 21, 2013
Noa E-Mailed - Sou Required From Applicant
Mar 26, 2013
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2013
Published For Opposition
Mar 6, 2013
Notification Of Notice Of Publication E-Mailed
Feb 21, 2013
Law Office Publication Review Completed
Feb 21, 2013
Assigned To Lie
Feb 6, 2013
Approved For Pub - Principal Register
Feb 6, 2013
Examiner's Amendment Entered
Feb 6, 2013
Notification Of Examiners Amendment E-Mailed
Feb 6, 2013
Examiners Amendment E-Mailed
Feb 6, 2013
Examiners Amendment -Written
Feb 6, 2013
Notification Of Non-Final Action E-Mailed
Feb 6, 2013
Non-Final Action E-Mailed
Feb 6, 2013
Non-Final Action Written
Jan 30, 2013
Assigned To Examiner
Oct 10, 2012
Notice Of Design Search Code Mailed
Oct 9, 2012
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24